V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300007682 | 300004755 | 0 | 64.2 | Curative (C) | 2014-07-07 | 2015-03-08 | Cisplatin + Fluorouracil + RT 5day | N | Y | 300017834 | CARBOPLATIN + RT |
| 300007683 | 300006969 | 1.58 | 47 | Neo-adjuvant (N) | null | 2013-08-09 | Cisplatin 7 day | null | null | 300017857 | PEMETREXED |
| 300007684 | 300004762 | 1.49 | 50.7 | Neo-adjuvant (N) | 2013-07-16 | 2013-07-16 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 300017878 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300007685 | 300004763 | 1.57 | 0 | Curative (C) | null | 2014-06-17 | Ipilimumab | N | N | 300017880 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300007686 | 300004764 | 1.6 | 56.3 | Neo-adjuvant (N) | 2016-08-14 | 2017-03-19 | Oxaliplatin + Modified de Gramont | N | N | 300017888 | DAIICHI TRIAL |
| 300007687 | 300004765 | 1.75 | null | Curative (C) | null | 2017-04-18 | Capecitabine + Oxaliplatin 21day | null | N | 300017888 | CISPLATIN + FLUOROURACIL |
| 300007688 | 300004766 | 1.77 | null | Adjuvant (A) | 2016-11-05 | 2017-01-20 | Oxaliplatin + Modified de Gramont | 2 | N | 300017894 | CARBOPLATIN + CETUXIMAB + FU |
| 300007690 | 300004771 | null | null | Palliative (P) | 2017-10-15 | 2017-10-18 | Trial Unspecified | 2 | N | 300017913 | OXALIPLATIN + MDG |
| 300007691 | 300006982 | null | 88.7 | Adjuvant (A) | 2014-12-26 | 2015-01-23 | Cisplatin | N | N | 300017931 | OXALIPLATIN + MDG |
| 300007692 | 300004776 | 1.61 | 115 | Curative (C) | 2015-09-04 | 2015-11-01 | Hydroxycarbamide | N | N | 300017933 | OXALIPLATIN + MDG |
| 300007693 | 300004778 | 1.67 | null | Curative (C) | 2016-02-04 | 2016-02-05 | CETUXIMAB | null | null | 300017947 | TRIAL |
| 300007694 | 300004782 | 1.65 | 63.3 | Curative (C) | 2017-08-11 | 2017-08-30 | Cisplatin 7 day | N | Y | 300017954 | CAPECITABINE + CISPLATIN + RT |
| 300007695 | 300006985 | 1.62 | 82.4 | Curative (C) | 2017-06-05 | 2017-06-07 | FLUOROURACIL + OXALIPLATIN | N | N | 300017959 | CISPLATIN + FLUOROURACIL |
| 300007696 | 300004785 | null | 82.5 | Adjuvant (A) | null | 2014-07-24 | Gemcitabine + Capecitabine | 2 | N | 300017986 | CAPECITABINE |
| 300007697 | 300004796 | 1.74 | 109.25 | Palliative (P) | 2018-09-19 | 2018-09-23 | Folfirinox | N | N | 300022305 | CISPLATIN |
| 300007698 | 300004798 | 1.68 | 86.1 | null | 2016-06-15 | 2016-06-15 | ESPAC-4 TRIAL | Y | null | 300022313 | ESPAC TRIAL |
| 300007699 | 300004803 | 1.73 | 60 | Curative (C) | 2017-10-18 | 2017-10-22 | CARBOPLATIN + ETOPOSIDE | 2 | N | 300022333 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007700 | 300004803 | 1.53 | 76.2 | Curative (C) | 2016-04-30 | 2016-05-05 | Trial Unspecified | 2 | N | 300022333 | TRIAL |
| 300007701 | 300004811 | null | null | Curative (C) | null | 2016-08-03 | Trial Unspecified | null | null | 300022410 | CAPECITABINE + GEMCITABINE |
| 300007703 | 300004814 | 1.6 | 96.9 | Disease modification (D) | 2018-04-24 | 2018-05-10 | GemCarbo Days 1+8 | 02 | N | 300022428 | OXALIPLATIN + RALTITREXED |
| 300007704 | 300004815 | 1.63 | 74 | Palliative (P) | null | 2017-03-24 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 300022430 | CETUXIMAB |
| 300007705 | 300004818 | 1.78 | null | null | 2014-12-02 | 2015-11-02 | Folfirinox | 02 | null | 300022453 | GEMCARBO |
| 300007707 | 300004823 | 1.75 | 71.5 | null | 2014-07-30 | 2014-07-30 | CARBOPLATIN + PACLITAXEL | N | null | 300022474 | CARBOPLATIN + PACLITAXEL |
| 300007708 | 300004827 | 1.82 | 81 | Neo-adjuvant (N) | 2014-02-28 | 2014-07-19 | Ipilimumab | N | N | 300022505 | OXALIPLATIN + MDG |
| 300007709 | 300004830 | null | 76.2 | Neo-adjuvant (N) | 2017-08-31 | 2017-09-01 | Trial Unspecified | N | N | 300022549 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300007710 | 300004831 | 1.56 | 85.5 | Curative (C) | 2015-02-03 | 2015-02-13 | CAPECITABINE + RT | N | N | 300022551 | OXALIPLATIN + MDG |
| 300007713 | 300004838 | 1.74 | null | Palliative (P) | 2017-08-17 | 2017-09-10 | ECarboX | 02 | N | 300022645 | OXALIPLATIN + MDG |
| 300007714 | 300004841 | 1.69 | null | Neo-adjuvant (N) | 2016-04-28 | 2016-04-28 | CARBOPLATIN + PACLITAXEL | null | null | 300022662 | CAPECITABINE + OXALIPLATIN |
| 300007715 | 300004843 | 1.65 | null | Curative (C) | null | 2014-05-13 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 300022675 | PACLITAXEL |
| 300007716 | 300004847 | 1.76 | 73.4 | Neo-adjuvant (N) | null | 2017-08-21 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 300022711 | OXALIPLATIN + MDG |
| 300007717 | 300004849 | 1.77 | null | Curative (C) | 2016-05-03 | 2016-05-18 | Folfirinox | 02 | null | 300022727 | CETUXIMAB |
| 300007718 | 300004852 | 1.49 | 85.5 | Curative (C) | 2017-07-14 | 2017-09-09 | Carboplatin + Etoposide iv&po | 02 | N | 300022737 | CAPECITABINE + OXALIPLATIN |
| 300007720 | 300004858 | 1.78 | 69.1 | Palliative (P) | 2015-03-28 | 2015-04-05 | Cetuximab + CISPLATIN + FLUOROURACIL | 2 | N | 300022846 | CETUXIMAB |
| 300007722 | 300004864 | 1.61 | 53.5 | Palliative (P) | null | 2017-02-26 | IVA | null | null | 300022956 | CISPLATIN |
| 300007723 | 300004865 | 1.57 | 65 | Palliative (P) | 2017-11-09 | 2017-11-16 | Trial Unspecified | N | N | 300022967 | TRIAL |
| 300007724 | 300004871 | 1.62 | 101 | Curative (C) | 2016-07-18 | 2016-07-23 | Trial Unspecified | 2 | null | 300023002 | CISPLATIN |
| 300007725 | 300007815 | 1.58 | 91 | Curative (C) | null | 2016-10-17 | ESPAC-4 TRIAL | 2 | N | 300023068 | ESPAC TRIAL |
| 300007726 | 300007021 | 1.77 | 90.4 | Palliative (P) | 2016-03-06 | 2016-03-06 | Carboplatin + Cetux + FU (Cycle 1) | N | N | 300023085 | CAPECITABINE + OXALIPLATIN |
| 300007727 | 300004877 | 1.84 | 50.1 | Palliative (P) | null | 2015-01-26 | Capecitabine | null | N | 300023175 | OXALIPLATIN + MDG |
| 300007728 | 300004879 | 1.59 | 53.55 | Curative (C) | 2015-01-14 | 2015-03-13 | Alemtuzumab + Cyclophos TBI Allo | N | Y | 300023187 | CETUXIMAB + RT |
| 300007729 | 300004882 | 1.67 | 111.85 | Curative (C) | 2013-03-21 | 2013-04-28 | OXALIPLATIN | null | N | 300023188 | CISPLATIN |
| 300007730 | 300004885 | 1.84 | 85.9 | Neo-adjuvant (N) | 2015-05-12 | 2015-06-27 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300023243 | GEMCITABINE + OXALIPLATIN |
| 300007731 | 300004887 | 1.67 | 62.3 | Curative (C) | 2014-12-12 | 2014-12-17 | Cetuximab 7 day (>Cycle 2) | 02 | Y | 300023270 | CISPLATIN + FLUOROURACIL |
| 300007732 | 300004893 | null | 91.5 | null | 2015-02-02 | 2015-02-02 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | 300023390 | OXALIPLATIN + MDG |
| 300007733 | 300007028 | 1.58 | 79.9 | Neo-adjuvant (N) | 2013-11-24 | 2014-09-20 | NPC Cisplatin/5 flourouracil | null | null | 300023404 | CISPLATIN |
| 300007734 | 300004897 | 1.65 | 55.6 | Palliative (P) | 2015-04-09 | 2015-04-14 | Trial Unspecified | N | N | 300023449 | CAPECITABINE + OXALIPLATIN |
| 300007735 | 300004899 | 1.6 | 60.5 | null | 2018-01-07 | 2018-01-07 | Capecitabine | 99 | null | 300023470 | OXALIPLATIN + MDG |
| 300007736 | 300004901 | null | 70 | Curative (C) | 2017-07-30 | 2017-08-02 | Carboplatin AUC 6 - 10 | N | null | 300023483 | DE-ESCALATE TRIAL |
| 300007737 | 300007033 | 1.63 | 149.1 | Neo-adjuvant (N) | 2012-09-23 | 2012-09-24 | Carboplatin + Pemetrexed | 2 | N | 300023503 | GEMCARBO |
| 300007738 | 300004905 | 1.61 | 44.6 | Palliative (P) | 2015-11-09 | 2016-02-25 | CAPECITABINE + GEMCITABINE | N | N | 300023507 | CETUXIMAB |